By Yiqing Wang/WHRO State lawmakers have budgeted nearly $15 million over two years to help Virginia Medicaid cover gene therapy treatments for people with sickle cell disease, a move providers said could help patients access this complex treatment more easily. The funding is tied to a federal model designed to help Medicaid programs pay for expensive cell […]
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a current print subscriber, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
